Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2013
FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose paintingAntonetta C Houweling, Anne Lisa Wolf, Wouter V Vogel, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 4, 2016
IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumoniaLisa Wolf, Sandra Sapich, Anja Honecker, et al.
The American Journal of Emergency Medicine|September 21, 2021
Adherence to guideline creation recommendations for suicide prevention in the emergency department: A systematic reviewMichael P Wilson, Jaskiran Kaur, Lindsay Blake, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 27, 2011
TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activationShirong Liu, Yang Liu, Wenlin Hao, et al.
The Journal of Biological Chemistry|March 12, 2015
Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial ActivityTatos Akopian, Olga Kandror, Christopher Tsu, et al.
Journal of Emergency Nursing|March 15, 2015
Ethical issues in the response to Ebola virus disease in US emergency departments: a position paper of the American College of Emergency Physicians, the Emergency Nurses Association and the Society for Academic Emergency MedicineArvind Venkat, Lisa Wolf, Joel M Geiderman, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 24, 2015
Ethical issues in the response to Ebola virus disease in United States emergency departments: a position paper of the American College of Emergency Physicians, the Emergency Nurses Association, and the Society for Academic Emergency MedicineArvind Venkat, Shellie L Asher, Lisa Wolf, et al.
The Lancet. HIV|April 3, 2020
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trialKelly E Dooley, Radojkam Savic, Akshay Gupte, et al.
Drug Safety|December 2, 2022
The Food and Drug Administration's (FDA's) Drug Safety Surveillance During the COVID-19 PandemicIda-Lina Diak, Kimberley Swank, Kate McCartan, et al.
Journal of the National Cancer Center|July 22, 2024
Quality assurance and safety of hippocampal avoidance prophylactic cranial irradiation in the multicenter randomized phase III trial (NCT01780675)Oscar Candiff, José Belderbos, Anne Lisa Wolf, et al.
Pageof 7